TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Asia Pacific Disulfiram market size was valued at USD 42.3 million in 2024 and is projected to reach USD 53.6 million by 2030, at a CAGR of 4.0% during the forecast period 2024-2030.
Disulfiram is a medication used to treat chronic alcoholism by causing an acute sensitivity to alcohol, also explored for potential applications in cancer treatment and as an antiviral agent.
The Asia Pacific disulfiram market is growing steadily, primarily driven by its use in alcohol addiction treatment. India leads with a 35% market share, followed by China at 30% and Japan at 20%. In 2024, alcohol addiction treatment accounted for 85% of total consumption, with research applications in oncology at 10% and antiviral studies at 5%. The market experienced a 7% growth in demand due to increasing awareness of alcohol use disorders. Key players include Zhejiang Chengyi Pharmaceutical Co., Ltd. (China) and Brocacef Supplies & Services (Netherlands), holding a combined 45% market share in the region. The industry is investing in novel formulations, with a 12% increase in R&D spending on extended-release preparations in 2024. Challenges include side effects and compliance issues, leading to a 15% focus on patient education programs. Recent research into disulfiram's potential in cancer treatment has driven an 8% increase in clinical trials. The market is benefiting from government initiatives to combat alcohol addiction, with a 10% rise in public health programs incorporating disulfiram therapy.
Report Includes
This report is an essential reference for who looks for detailed information on Asia Pacific Disulfiram . The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Disulfiram , including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user's requirements is also available.
This report aims to provide a comprehensive presentation of the Asia Pacific Disulfiram , with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Disulfiram . This report contains market size and forecasts of Disulfiram in Asia Pacific, including the following market information:
We surveyed the Disulfiram manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
The report also provides analysis of leading market participants including:
Key Points of this Report:
Reasons to Purchase this Report:
1.1 Product Overview and Scope of Disulfiram
1.2.1 Asia Pacific Market Size YoY Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 97% Purity
1.2.3 98% Purity
1.2.4 99% Purity
1.3.1 Asia Pacific Market Size YoY Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Industrial Application
1.3.3 Chemical Industry
1.3.4 Other
1.4 Asia Pacific Market Growth Prospects
1.4.1 Asia Pacific Revenue Estimates and Forecasts (2019-2030)
1.4.2 Asia Pacific Production Estimates and Forecasts (2019-2030)
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 PESTEL Analysis
2.1.3 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
3.1 Asia Pacific Production by Manufacturers (2019-2023)
3.2 Asia Pacific Revenue Market Share by Manufacturers (2019-2023)
3.3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Asia Pacific Average Price by Manufacturers (2019-2023)
3.5 Manufacturers Production Sites, Area Served, Product Type
3.6 Market Competitive Situation and Trends
3.6.1 Market Concentration Rate
3.6.2 Asia Pacific 5 and 10 Largest Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4.1 Asia Pacific Production
4.1.1 Asia Pacific Production YoY Growth Rate (2019-2023)
4.1.2 Asia Pacific Production, Revenue, Price and Gross Margin (2019-2024)
5.1 Asia Pacific
5.1.1 Asia Pacific Consumption by Country
5.1.2 Asia Pacific Sales, Consumption, Export, Import (2019-2023)
5.1.1 China
5.2.2 India
5.3.3 Japan
5.4.4 South Korea
5.5.5 Australia
5.6.6 Thailand
5.7.7 Indonesia
6.1 Asia Pacific Production Market Share by Type (2019-2024)
6.2 Asia Pacific Revenue Market Share by Type (2019-2024)
6.3 Asia Pacific Price by Type (2019-2024)
7.1 Asia Pacific Production Market Share by Application (2019-2024)
7.2 Asia Pacific Revenue Market Share by Application (2019-2024)
7.3 Asia Pacific Price by Application (2019-2024)
8.1 Zhejiang Hisun Pharmaceutical Co., Ltd.
8.1.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Corporation Information
8.1.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Product Portfolio
8.1.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.1.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Main Business and Markets Served
8.1.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments/Updates
8.2 Jiangsu Hengrui Medicine Co., Ltd.
8.2.1 Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
8.2.2 Jiangsu Hengrui Medicine Co., Ltd. Product Portfolio
8.2.3 Jiangsu Hengrui Medicine Co., Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.2.4 Jiangsu Hengrui Medicine Co., Ltd. Main Business and Markets Served
8.2.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments/Updates
8.3 Lupin Limited
8.3.1 Lupin Limited Corporation Information
8.3.2 Lupin Limited Product Portfolio
8.3.3 Lupin Limited Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.3.4 Lupin Limited Main Business and Markets Served
8.3.5 Lupin Limited Recent Developments/Updates
8.4 Sun Pharmaceutical Industries Ltd.
8.4.1 Sun Pharmaceutical Industries Ltd. Corporation Information
8.4.2 Sun Pharmaceutical Industries Ltd. Product Portfolio
8.4.3 Sun Pharmaceutical Industries Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.4.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
8.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
8.5 Dr. Reddy's Laboratories Ltd.
8.5.1 Dr. Reddy's Laboratories Ltd. Corporation Information
8.5.2 Dr. Reddy's Laboratories Ltd. Product Portfolio
8.5.3 Dr. Reddy's Laboratories Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.5.4 Dr. Reddy's Laboratories Ltd. Main Business and Markets Served
8.5.5 Dr. Reddy's Laboratories Ltd. Recent Developments/Updates
8.6 Cipla Ltd.
8.6.1 Cipla Ltd. Corporation Information
8.6.2 Cipla Ltd. Product Portfolio
8.6.3 Cipla Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.6.4 Cipla Ltd. Main Business and Markets Served
8.6.5 Cipla Ltd. Recent Developments/Updates
8.7 Aurobindo Pharma
8.7.1 Aurobindo Pharma Corporation Information
8.7.2 Aurobindo Pharma Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.7.3 Aurobindo Pharma Main Business and Markets Served
8.7.4 Aurobindo Pharma Recent Developments/Updates
8.8 Glenmark Pharmaceuticals
8.8.1 Glenmark Pharmaceuticals Corporation Information
8.8.2 Glenmark Pharmaceuticals Product Portfolio
8.8.3 Glenmark Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.8.4 Glenmark Pharmaceuticals Main Business and Markets Served
8.8.5 Glenmark Pharmaceuticals Recent Developments/Updates
8.9 Cadila Healthcare
8.9.1 Cadila Healthcare Corporation Information
8.9.2 Cadila Healthcare Product Portfolio
8.9.3 Cadila Healthcare Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.9.4 Cadila Healthcare Main Business and Markets Served
8.9.5 Cadila Healthcare Recent Developments/Updates
8.10 Torrent Pharmaceuticals Ltd.
8.10.1 Torrent Pharmaceuticals Ltd. Corporation Information
8.10.2 Torrent Pharmaceuticals Ltd. Product Portfolio
8.10.3 Torrent Pharmaceuticals Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.10.4 Torrent Pharmaceuticals Ltd. Main Business and Markets Served
8.10.5 Torrent Pharmaceuticals Ltd. Recent Developments/Updates
9.1 Key Raw Materials Analysis
9.1.1 Key Raw Materials
9.1.2 Key Suppliers of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
9.3 Manufacturing Process Analysis of Disulfiram
9.4 Industrial Chain Analysis
10.1 Marketing Channel
10.2 Distributors List
10.3 Customers
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12.1 Asia Pacific Production, Revenue Forecast (2024-2030)
13.1 Asia Pacific Forecasted Consumption of by Country
14.1 Asia Pacific Production, Revenue and Price Forecast by Type (2024-2030)
14.1.1 Asia Pacific Forecasted Production of by Type (2024-2030)
14.1.2 Asia Pacific Forecasted Revenue of by Type (2024-2030)
14.1.3 Asia Pacific Forecasted Price of by Type (2024-2030)
14.2 Asia Pacific Production, Revenue and Price Forecast by Application (2024-2030)
14.2.1 Asia Pacific Forecasted Production of by Application (2024-2030)
14.2.2 Asia Pacific Forecasted Revenue of by Application (2024-2030)
14.2.3 Asia Pacific Forecasted Price of by Application (2024-2030)
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Author List
16.4 Disclaimer
17.1 Note
17.2 Examples of Clients
Frequently Asked Questions ?
